DOCSLIB.ORG

Inflammatory, Regulatory, and Autophagy Co-Expression Modules and Hub Genes Underlie the Peripheral Immune Response to Human Intracerebral Hemorrhage

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Inflammatory, Regulatory, and Autophagy Co-Expression Modules and Hub Genes Underlie the Peripheral Immune Response to Human Intracerebral Hemorrhage UC Davis UC Davis Previously Published Works Title Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage. Permalink https://escholarship.org/uc/item/0gb9d6sh Journal Journal of neuroinflammation, 16(1) ISSN 1742-2094 Authors Durocher, Marc Ander, Bradley P Jickling, Glen et al. Publication Date 2019-03-05 DOI 10.1186/s12974-019-1433-4 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Durocher et al. Journal of Neuroinflammation (2019) 16:56 https://doi.org/10.1186/s12974-019-1433-4 RESEARCH Open Access Inflammatory, regulatory, and autophagy co-expression modules and hub genes underlie the peripheral immune response to human intracerebral hemorrhage Marc Durocher1, Bradley P. Ander1, Glen Jickling1, Farah Hamade1, Heather Hull1, Bodie Knepp1, Da Zhi Liu1, Xinhua Zhan1, Anh Tran1, Xiyuan Cheng1, Kwan Ng1, Alan Yee1, Frank R. Sharp1 and Boryana Stamova1,2* Abstract Background: Intracerebral hemorrhage (ICH) has a high morbidity and mortality. The peripheral immune system and cross-talk between peripheral blood and brain have been implicated in the ICH immune response. Thus, we delineated the gene networks associated with human ICH in the peripheral blood transcriptome. We also compared the differentially expressed genes in blood following ICH to a prior human study of perihematomal brain tissue. Methods: We performed peripheral blood whole-transcriptome analysis of ICH and matched vascular risk factor control subjects (n = 66). Gene co-expression network analysis identified groups of co-expressed genes (modules) associated with ICH and their most interconnected genes (hubs). Mixed-effects regression identified differentially expressed genes in ICH compared to controls. Results: Of seven ICH-associated modules, six were enriched with cell-specific genes: one neutrophil module, one neutrophil plus monocyte module, one T cell module, one Natural Killer cell module, and two erythroblast modules. The neutrophil/monocyte modules were enriched in inflammatory/immune pathways; the T cell module in T cell receptor signaling genes; and the Natural Killer cell module in genes regulating alternative splicing, epigenetic, and post-translational modifications. One erythroblast module was enriched in autophagy pathways implicated in experimental ICH, and NRF2 signaling implicated in hematoma clearance. Many hub genes or module members, such as IARS, mTOR, S1PR1, LCK, FYN, SKAP1, ITK, AMBRA1, NLRC4, IL6R, IL17RA, GAB2, MXD1, PIK3CD, NUMB, MAPK14, DDX24, EVL, TDP1, ATG3, WDFY3, GSK3B, STAT3, STX3, CSF3R, PIP4K2A, ANXA3, DGAT2, LRP10, FLOT2, ANK1, CR1, SLC4A1, and DYSF, have been implicated in neuroinflammation, cell death, transcriptional regulation, and some as experimental ICH therapeutic targets. Gene-level analysis revealed 1225 genes (FDR p < 0.05, fold-change > |1.2|) have altered expression in ICH in peripheral blood. There was significant overlap of the 1225 genes with dysregulated genes in human perihematomal brain tissue (p =7×10−3). Overlapping genes were enriched for neutrophil-specific genes (p =6.4×10−08) involved in interleukin, neuroinflammation, apoptosis, and PPAR signaling. (Continued on next page) * Correspondence: [email protected] 1Department of Neurology, University of California Davis School of Medicine, Sacramento, CA 95817, USA 2MIND Institute Biosciences Building, 2805 50th Street, Sacramento, CA 95817, USA © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Durocher et al. Journal of Neuroinflammation (2019) 16:56 Page 2 of 21 (Continued from previous page) Conclusions: This study delineates key processes underlying ICH pathophysiology, complements experimental ICH findings, and the hub genes significantly expand the list of novel ICH therapeutic targets. The overlap between blood and brain gene responses underscores the importance of examining blood-brain interactions in human ICH. Keywords: Intracerebral hemorrhage, ICH, NRF2, Autophagy, Hematoma, Hematoma clearance, Src kinase inhibitors, Gene expression, Co-expression networks, Gene networks Introduction animal ICH models. The findings also highlight candidate Approximately 795,000 strokes occur in the USA each genes that influence major processes underlying the re- year [1]. Stroke remains a leading cause of death and sponse to ICH and parallel responding genes/pathways in disability [2, 3]. Although primary non-traumatic intra- blood and brain, underscoring the importance of further cerebral hemorrhage (ICH) only accounts for 10–15% of studies of the peripheral blood-brain immune strokes [1, 4], its mortality rate of 59% at 1 year [4]is communication. much higher than that for ischemic stroke (IS) (14%) [5]. Many pre-clinical and a few clinical studies implicate Materials and methods neuroinflammation as contributing to neurological injury Study subjects produced by ICH [3, 6, 7]. Following ICH, a complex cas- Sixty-six male (M) and female (F) subjects with intrace- cade of local and systemic immune responses occurs lead- rebral hemorrhage (ICH, n = 33, 24 M/9F) and vascular ing to blood-brain barrier disruption, cerebral edema, and risk factor (VRF)-matched control subjects (CTRL, n = cell damage/death followed by hematoma removal and 33, 24 M/9F) were recruited from the Universities of brain repair [7–11]. Since there is communication between California at Davis and San Francisco as well as the Uni- the peripheral immune system and the central nervous sys- versity of Alberta, Canada. Procedures were approved by tem through afferent and efferent trafficking of cells and the IRBs at participating universities and written in- molecules, the peripheral immune system is a key driver of formed consent was obtained from participants or their damage and repair following ICH [7, 12, 13]. Peripheral proxy. ICH was diagnosed by board-certified neurolo- leukocytic infiltration into the brain is seen early following gists based upon histories, exams, and magnetic reson- ICH [7]. This involves chemokines, cytokines, matrix me- ance imaging (MRI) and/or computed tomographic (CT) talloproteinases (MMPs), and interactions between circulat- brain scan [16]. Subjects were matched for age, race, sex, ing leukocytes and vascular endothelial cells, with different and VRFs, which included hypertension, diabetes melli- cell types employing common as well as unique pathways tus, hyperlipidemia, and smoking status. Exclusion cri- [14]. Thus, it is important to study both the local and sys- teria were previous stroke (for CTRLs) and ischemic temic immune response to human ICH. stroke with hemorrhagic transformation. We examined the systemic peripheral immune response to human ICH and how it compares to the local human Blood collection, RNA isolation perihematomal brain tissue response. We investigated the Blood was collected in PAXgene tubes and RNA isolated peripheral blood gene co-expression networks and their as previously described [17, 18]. There was a single most interconnected genes (hubs) following ICH, identi- blood draw per subject. Time after symptom onset for fied differential gene-level RNA expression and the poten- ICH varied from 4.2 to 124.3 h. tially affected pathways, and compared the peripheral blood response to the one in previously published human Arrays and processing peri-hematoma ICH brain [15]. The hub genes we identi- RNA was processed on the GeneChip® Human Tran- fied have been implicated as major regulators of the im- scriptome Array (HTA) 2.0 (Affymetrix, Santa Clara, mune response including the inflammasome, autophagy, CA) which examines the coding and non-coding tran- and transcriptional and epigenetic regulation. Some of the scriptome. Raw expression values for each gene were hub genes have also been successfully tested in animal saved in Affymetrix.CEL and Affymetrix.DAT files. Using ICH models. Notably, there was a significant overlap be- Affymetrix Power Tools (APT), the. CEL transformer tween genes differentially expressed in this human ICH applied GC correction (GCCN) and single space trans- peripheral blood study compared to a prior human study formation (SST) to the HTA.CEL files. GCCN-SST of perihematomal brain tissue [15]. These findings will transformations were conducted through a command further our understanding of the biological processes oc- line using APT 1.18.0 in “batch” mode. GCCN-SST curring following ICH, as well as provide human data con- transformed .CEL files were uploaded into Partek Flow firming targets that have been tested or will be tested in software (Partek Inc., St. Louis, MO) and probe sets Durocher et al. Journal of Neuroinflammation (2019) 16:56 Page 3 of 21 mapped to the Human Genome hg19 using the STAR (false-discovery rate) p value < 0.05 and a fold change 2.4.1d aligner. Nominal read coverage depth was defined (FC) > |1.2| for ICH vs CTRL were considered as 30 million and default mapping parameters were significant.
Load more

Recommended publications
  • A61K9/00 (2006.01) G01N 2 7/447 (2006.01) Chusetts 02139 (US)
    ( (51) International Patent Classification: (74) Agent: SCARR, Rebecca B. et al.; McNeill Baur PLLC, C07K 16/28 (2006.01) A61K 35/00 (2006.01) 125 Cambridge Park Drive, Suite 301, Cambridge, Massa¬ A61K9/00 (2006.01) G01N 2 7/447 (2006.01) chusetts 02139 (US). A61K9/19 (2006.01) C07K 19/00 (2006.01) (81) Designated States (unless otherwise indicated, for every (21) International Application Number: kind of national protection av ailable) . AE, AG, AL, AM, PCT/US2020/036035 AO, AT, AU, AZ , BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, (22) International Filing Date: DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, 04 June 2020 (04.06.2020) HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, (25) Filing Language: English KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (26) Publication Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (30) Priority Data: SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, 62/857,364 05 June 2019 (05.06.2019) US TT, TZ, UA, UG, US, UZ, VC, VN, WS, ZA, ZM, ZW. 62/906,862 27 September 2019 (27.09.2019) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: SEATTLE GENETICS, INC. [US/US]; kind of regional protection available) . ARIPO (BW, GH, 21823 30th Drive SE, Bothell, Washington 98021 (US).
    [Show full text]
  • In Vivo Imaging of Tgfβ Signalling Components Using Positron
    REVIEWS Drug Discovery Today Volume 24, Number 12 December 2019 Reviews KEYNOTE REVIEW In vivo imaging of TGFb signalling components using positron emission tomography 1 1 2 Lonneke Rotteveel Lonneke Rotteveel , Alex J. Poot , Harm Jan Bogaard , received her MSc in drug 3 1 discovery and safety at the Peter ten Dijke , Adriaan A. Lammertsma and VU University in 1 Amsterdam. She is Albert D. Windhorst currently finishing her PhD at the VU University 1 Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands Medical Center (VUmc) 2 under the supervision of A. Pulmonary Medicine, Institute for Cardiovascular Research, Amsterdam UMC, location VUmc, Amsterdam, The Netherlands D. Windhorst and Adriaan A. Lammertsma. Her 3 research interest is on the development of positron Department of Cell and Chemical Biology, Oncode Institute, Leiden University Medical Center, Leiden, The emission tomography (PET) tracers that target Netherlands selectively the activin receptor-like kinase 5 in vitro and in vivo. Alex J. Poot obtained his The transforming growth factor b (TGFb) family of cytokines achieves PhD in medicinal chemistry homeostasis through a careful balance and crosstalk with complex from Utrecht University. As postdoctoral researcher at signalling pathways. Inappropriate activation or inhibition of this pathway the VUmc, Amsterdam, he and mutations in its components are related to diseases such as cancer, developed radiolabelled anticancer drugs for PET vascular diseases, and developmental disorders. Quantitative imaging of imaging. In 2014, he accepted a research expression levels of key regulators within this pathway using positron fellowship from Memorial Sloan Kettering Cancer 13 emission tomography (PET) can provide insights into the role of this Center, New York to develop C-labelled probes for tumour metabolism imaging with magnetic resonance in vivo pathway , providing information on underlying pathophysiological imaging (MRI).
    [Show full text]
  • How Relevant Are Bone Marrow-Derived Mast Cells (Bmmcs) As Models for Tissue Mast Cells? a Comparative Transcriptome Analysis of Bmmcs and Peritoneal Mast Cells
    cells Article How Relevant Are Bone Marrow-Derived Mast Cells (BMMCs) as Models for Tissue Mast Cells? A Comparative Transcriptome Analysis of BMMCs and Peritoneal Mast Cells 1, 2, 1 1 2,3 Srinivas Akula y , Aida Paivandy y, Zhirong Fu , Michael Thorpe , Gunnar Pejler and Lars Hellman 1,* 1 Department of Cell and Molecular Biology, Uppsala University, The Biomedical Center, Box 596, SE-751 24 Uppsala, Sweden; [email protected] (S.A.); [email protected] (Z.F.); [email protected] (M.T.) 2 Department of Medical Biochemistry and Microbiology, Uppsala University, The Biomedical Center, Box 589, SE-751 23 Uppsala, Sweden; [email protected] (A.P.); [email protected] (G.P.) 3 Department of Anatomy, Physiology and Biochemistry, Swedish University of Agricultural Sciences, Box 7011, SE-75007 Uppsala, Sweden * Correspondence: [email protected]; Tel.: +46-(0)18-471-4532; Fax: +46-(0)18-471-4862 These authors contributed equally to this work. y Received: 29 July 2020; Accepted: 16 September 2020; Published: 17 September 2020 Abstract: Bone marrow-derived mast cells (BMMCs) are often used as a model system for studies of the role of MCs in health and disease. These cells are relatively easy to obtain from total bone marrow cells by culturing under the influence of IL-3 or stem cell factor (SCF). After 3 to 4 weeks in culture, a nearly homogenous cell population of toluidine blue-positive cells are often obtained. However, the question is how relevant equivalents these cells are to normal tissue MCs. By comparing the total transcriptome of purified peritoneal MCs with BMMCs, here we obtained a comparative view of these cells.
    [Show full text]
  • A Cytokine Protein-Protein Interaction Network for Identifying Key Molecules in Rheumatoid Arthritis
    RESEARCH ARTICLE A cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis Venugopal Panga1,2, Srivatsan Raghunathan1* 1 Institute of Bioinformatics and Applied Biotechnology (IBAB), Biotech Park, Electronics City Phase I, Bengaluru, Karnataka, India, 2 Manipal Academy of Higher Education, Manipal, Karnataka, India * [email protected] a1111111111 a1111111111 a1111111111 a1111111111 Abstract a1111111111 Rheumatoid arthritis (RA) is a chronic inflammatory disease of the synovial joints. Though the current RA therapeutics such as disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs) and biologics can halt the progression of the disease, none of these would either dramatically reduce or cure RA. So, the identification of OPEN ACCESS potential therapeutic targets and new therapies for RA are active areas of research. Several Citation: Panga V, Raghunathan S (2018) A studies have discovered the involvement of cytokines in the pathogenesis of this disease. cytokine protein-protein interaction network for identifying key molecules in rheumatoid arthritis. These cytokines induce signal transduction pathways in RA synovial fibroblasts (RASF). PLoS ONE 13(6): e0199530. https://doi.org/ These pathways share many signal transducers and their interacting proteins, resulting in 10.1371/journal.pone.0199530 the formation of a signaling network. In order to understand the involvement of this network Editor: Hua Zhou, Macau University of Science and in RA pathogenesis, it is essential to identify the key transducers and their interacting pro- Technology, MACAO teins that are part of this network. In this study, based on a detailed literature survey, we Received: August 21, 2017 have identified a list of 12 cytokines that induce signal transduction pathways in RASF.
    [Show full text]
  • Comparing Tools for Non-Coding RNA Multiple Sequence Alignment Based On
    Downloaded from rnajournal.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press ES Wright 1 1 TITLE 2 RNAconTest: Comparing tools for non-coding RNA multiple sequence alignment based on 3 structural consistency 4 Running title: RNAconTest: benchmarking comparative RNA programs 5 Author: Erik S. Wright1,* 6 1 Department of Biomedical Informatics, University of Pittsburgh (Pittsburgh, PA) 7 * Corresponding author: Erik S. Wright ([email protected]) 8 Keywords: Multiple sequence alignment, Secondary structure prediction, Benchmark, non- 9 coding RNA, Consensus secondary structure 10 Downloaded from rnajournal.cshlp.org on September 26, 2021 - Published by Cold Spring Harbor Laboratory Press ES Wright 2 11 ABSTRACT 12 The importance of non-coding RNA sequences has become increasingly clear over the past 13 decade. New RNA families are often detected and analyzed using comparative methods based on 14 multiple sequence alignments. Accordingly, a number of programs have been developed for 15 aligning and deriving secondary structures from sets of RNA sequences. Yet, the best tools for 16 these tasks remain unclear because existing benchmarks contain too few sequences belonging to 17 only a small number of RNA families. RNAconTest (RNA consistency test) is a new 18 benchmarking approach relying on the observation that secondary structure is often conserved 19 across highly divergent RNA sequences from the same family. RNAconTest scores multiple 20 sequence alignments based on the level of consistency among known secondary structures 21 belonging to reference sequences in their output alignment. Similarly, consensus secondary 22 structure predictions are scored according to their agreement with one or more known structures 23 in a family.
    [Show full text]
  • U4 Small Nuclear RNA Dissociates from a Yeast Spliceosome And
    MOLECULAR AND CELLULAR BIOLOGY, Nov. 1991, p. 5571-5577 Vol. 11, No. 11 0270-7306/91/115571-07$02.00/0 Copyright C) 1991, American Society for Microbiology U4 Small Nuclear RNA Dissociates from a Yeast Spliceosome and Does Not Participate in the Subsequent Splicing Reaction SHYUE-LEE YEAN AND REN-JANG LIN* Department of Microbiology, University of Texas at Austin, Austin, Texas 78712-1095 Received 16 April 1991/Accepted 19 August 1991 U4 and U6 small nuclear RNAs reside in a single ribonucleoprotein particle, and both are required for pre-mRNA splicing. The U4/U6 and U5 small nuclear ribonucleoproteins join Ul and U2 on the pre-mRNA during spliceosome assembly. Binding of U4 is then destabilized prior to or concomitant with the 5' cleavage-ligation. In order to test the role of U4 RNA, we isolated a functional spliceosome by using extracts prepared from yeast cells carrying a temperature-sensitive allele ofprp2 (rna2). The isolated prp2A spliceosome contains U2, U5, U6, and possibly also I11 and can be activated to splice the bound pre-mRNA. U4 RNA does not associate with the isolated spliceosomes and is shown not to be involved in the subsequent cleavage-ligation reactions. These results are consistent with the hypothesis that the role of U4 in pre-mRNA splicing is to deliver U6 to the spliceosome. Splicing of introns from nuclear pre-mRNAs occurs by mRNA in a spliceosome (19, 22). This prp2A spliceosome is two cleavage-ligation (transesterification) reactions. The first functional, since it can be activated to splice if supplemented reaction is a cleavage at the 5' splice site and the formation with splicing factors and ATP.
    [Show full text]
  • Mapping Macrophage Polarization Over the Myocardial Infarction Time Continuum
    Edinburgh Research Explorer Mapping macrophage polarization over the myocardial infarction time continuum Citation for published version: Mouton, AJ, DeLeon-Pennell, KY, Rivera Gonzalez, OJ, Flynn, ER, Freeman, TC, Saucerman, JJ, Garrett, MR, Ma, Y, Harmancey, R & Lindsey, ML 2018, 'Mapping macrophage polarization over the myocardial infarction time continuum', Basic research in cardiology, vol. 113, no. 4, pp. 26. https://doi.org/10.1007/s00395-018-0686-x Digital Object Identifier (DOI): 10.1007/s00395-018-0686-x Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Basic research in cardiology Publisher Rights Statement: This article is distributed under the terms of the Creative Commons Attribution, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation. If you believe that the public display of this file breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 07.
    [Show full text]
  • Activemax® Recombinant Human TGF-Beta 1 / TGFB1 Catalog # AMS.TG1-H4212 for Research and Further Cell Culture Manufacturing Use
    ActiveMax® Recombinant Human TGF-Beta 1 / TGFB1 Catalog # AMS.TG1-H4212 For Research and Further Cell Culture Manufacturing Use Description Source ActiveMax® Recombinant Human TGF-Beta 1 / TGFB1 (ActiveMax® Human TGF-Beta 1) Ala 279 - Ser 390 (Accession # NP_000651.3) was produced in human 293 cells (HEK293) Predicted N-terminus Ala 279 Molecular Characterization Endotoxin Less than 1.0 EU per μg of the ActiveMax® Human TGF-Beta 1 by the LAL method. Purity >95% as determined by SDS-PAGE of reduced (+) and non-reduced (-) rhTGFB1. Bioactivity The bio-activity was determined by its ability to inhibit IL-4 induced HT-2 cell proliferation. The ED50<0.05 ng/mL, corresponding to a specific activity of >2X107 Unit/mg Formulation and Storage Formulation Lyophilized from 0.22 μm filtered solution in TFA and acetonitrile. Normally Mannitol or Trehalose are added as protectants before lyophilization. Contact us for customized product form or formulation. Reconstitution See Certificate of Analysis for reconstitution instructions and specific concentrations. Storage Lyophilized Protein should be stored at -20℃ or lower for long term storage. Upon reconstitution, working aliquots should be stored at -20℃ or -70℃. Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: ● 4-8℃ for 12 months in lyophilized state; ● -70℃ for 3 months under sterile conditions after reconstitution. Background Background Transforming growth factor beta 1 ( TGFB1) is also known as TGF-β1, CED, DPD1, TGFB. is a polypeptide member of the transforming growth factor beta superfamily of cytokines. It is a secreted protein that performs many cellular functions, including the control of cell growth, cell proliferation, cell differentiation and apoptosis.
    [Show full text]
  • Beclin 1 Regulates Neuronal Transforming Growth Factor-Β Signaling by Mediating Recycling of the Type I Receptor ALK5 Caitlin E
    O’Brien et al. Molecular Neurodegeneration (2015) 10:69 DOI 10.1186/s13024-015-0065-0 RESEARCH ARTICLE Open Access Beclin 1 regulates neuronal transforming growth factor-β signaling by mediating recycling of the type I receptor ALK5 Caitlin E. O’Brien1,2,3, Liana Bonanno2,3,4, Hui Zhang2,3 and Tony Wyss-Coray2,3* Abstract Background: Beclin 1 is a key regulator of multiple trafficking pathways, including autophagy and receptor recycling in yeast and microglia. Decreased beclin 1 levels in the CNS result in neurodegeneration, an effect attributed to impaired autophagy. However, neurons also rely heavily on trophic factors, and signaling through these pathways requires the proper trafficking of trophic factor receptors. Results: We discovered that beclin 1 regulates signaling through the neuroprotective TGF-β pathway. Beclin 1 is required for recycling of the type I TGF-β receptor ALK5. We show that beclin 1 recruits the retromer to ALK5 and facilitates its localization to Rab11+ endosomes. Decreased levels of beclin 1, or its binding partners VPS34 and UVRAG, impair TGF-β signaling. Conclusions: These findings identify beclin 1 as a positive regulator of a trophic signaling pathway via receptor recycling, and suggest that neuronal death induced by decreased beclin 1 levels may also be due to impaired trophic factor signaling. Keywords: Beclin 1, VPS34, Retromer, TGF-β, ALK5, Protein sorting, Receptor recycling, Neurodegeneration Background Beclin 1 is highly expressed in the nervous system and Beclin 1 is a component of the type III is essential for neuronal survival. While beclin 1 knock- phosphatidylinositol-3-kinase (PI3K) complex.
    [Show full text]
  • Forward Genetics
    MOLECULAR AND CELLULAR BIOLOGY, Sept. 1992, p. 3939-3947 Vol. 12, No. 9 0270-7306/92/093939-09$02.00/0 Copyright X 1992, American Society for Microbiology PRP38 Encodes a Yeast Protein Required for Pre-mRNA Splicing and Maintenance of Stable U6 Small Nuclear RNA Levels STEVEN BLANTON, APARNA SRINIVASAN, AND BRIAN C. RYMOND* T. H. Morgan School ofBiological Sciences, University ofKentucky, Lexington, Kentucky 40506-0225 Downloaded from Received 7 April 1992/Returned for modification 14 May 1992/Accepted 17 June 1992 An essential pre-mRNA splicing factor, the product of the PRP38 gene, has been genetically identified in a screen of temperature-sensitive mutants of Saccharomyces cerevisiae. Shifting temperature-sensitive prp38 cultures from 23 to 37°C prevents the first cleavage-ligation event in the excision of introns from mRNA precursors. In vitro splicing inactivation and complementation studies suggest that the PRP38-encoded factor functions, at least in part, after stable splicing complex formation. The PRP38 locus contains a 726-bp open reading frame coding for an acidic 28-kDa polypeptide (PRP38). While PRP38 lacks obvious structural similarity to previously defined splicing factors, heat inactivation of PRP38, PRP19, or any of the known U6 http://mcb.asm.org/ (or U4/U6) small nuclear ribonucleoprotein-associating proteins (i.e., PRP3, PRP4, PRP6, and PRP24) leads to a common, unexpected consequence: intracellular U6 small nuclear RNA (snRNA) levels decrease as splicing activity is lost. Curiously, U4 snRNA, normally extensively base paired with U6 snRNA, persists in the virtual absence of U6 snRNA. The excision of intervening sequences from eukaryotic ates from the spliceosome (11, 37).
    [Show full text]
  • Domains of Yeast U4 Spliceosomal RNA Required for PRP4 Protein Binding, Snrnp-Snrnp Interactions, and Pre- Mrna Splicing in Vivo
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press Domains of yeast U4 spliceosomal RNA required for PRP4 protein binding, snRNP-snRNP interactions, and pre- mRNA splicing in vivo R6my Bordonn4, Josette Banroques,~, 2 John Abelson, 1 and Christine Guthrie s Department of Biochemistry and Biophysics, University of California at San Francisco, San Francisco, California 94143 USA; ~Division of Biology, California Institute of Technology, Pasadena, California 91125 USA U4 small nuclear RNA (snRNA) contains two intramolecular stem-loop structures, located near each end of the molecule. The 5' stem-loop is highly conserved in structure and separates two regions of U4 snRNA that base- pair with U6 snRNA in the U4/U6 small nuclear ribonucleoprotein particle (snRNP). The 3' stem-loop is highly divergent in structure among species and lies immediately upstream of the binding site for Sm proteins. To investigate the function of these two domains, mutants were constructed that delete the yeast U4 snRNA 5' stem-loop and that replace the yeast 3' stem-loop with that from trypanosome U4 snRNA. Both mutants fail to complement a null allele of the yeast U4 gene. The defects of the mutants have been examined in heterozygous strains by native gel electrophoresis, glycerol gradient centrifugation, and immunoprecipitation. The chimeric yeast-trypanosome RNA does not associate efficiently with U6 snRNA, suggesting that the 3' stem-loop of yeast U4 snRNA might be a binding site for a putative protein that facilitates assembly of the U4/U6 complex. In contrast, the 5' hairpin deletion mutant associates efficiently with U6 snRNA.
    [Show full text]
  • 14Th International Conference on Behçet's Disease
    14th International Conference on Behçet’s Disease London, United Kingdom, 8-10 July 2010 Executive Committee – International Society for Behçet’s Disease President Sungnack Lee (Korea) - Dermatology Past-President Hasan Yazici (Turkey) - Rheumatology Vice-President Kenneth Calamia (USA) - Rheumatology Secretary Dongsik Bang (Korea) - Dermatology Treasurer Samir Assaad Khalil (Egypt) - Internal Medicine President of 14th International Congress Dorian Haskard (UK) - Rheumatology President Past International Congress Michael Schirmer (Austria) - Rheumatology Member – Dermatology Eun-So Lee (Korea) - Dermatology Member – Internal Medicine Petros Sfikakis (Greece) - Internal Medicine Member – Scientific Affairs Haner Direskeneli (Turkey) - Rheumatology Member – Publication Affairs Graham Wallace (UK) - Immunology Hon. Life Presidents – International Society for Behçet’s Disease Colin G. Barnes (UK) - Rheumatology Nihat Dilsen (Turkey) - Rheumatology George Ehrlich (USA) - Rheumatology Thomas Lehner (UK) - Immunology Desmond O’Duffy (USA) - Rheumatology Local Organising Committee Honorary President Dorian Haskard (UK) - Rheumatology International Affairs Secretary Colin G. Barnes (UK) - Rheumatology Honorary General Secretary Graham Wallace (UK) - Immunology Farida Fortune (UK) - Oral Medicine Robert Moots (UK) - Rheumatology Miles Stanford (UK) - Ophthalmology Representatives – Behçet’s Syndrome Society Jan Mather (UK) - BSS Chris Phillips (UK) - BSS Abstracts page Oral Presentation index S-107 Oral Presentations S-108 Poster Presentations index
    [Show full text]